Determinants of Campylobacter infection and association with growth and enteric inflammation in children under 2 years of age in low-resource settings.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 11 2019
Historique:
received: 22 07 2019
accepted: 31 10 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 4 11 2020
Statut: epublish

Résumé

Campylobacter species infections have been associated with malnutrition and intestinal inflammation among children in low-resource settings. However, it remains unclear whether that association is specific to Campylobacter jejuni/coli. The aim of this study was to assess the association between both all Campylobacter species infections and Campylobacter jejuni/coli infections on growth and enteric inflammation in children aged 1-24 months. We analyzed data from 1715 children followed from birth until 24 months of age in the MAL-ED birth cohort study, including detection of Campylobacter species by enzyme immunoassay and Campylobacter jejuni/coli by quantitative PCR in stool samples. Myeloperoxidase (MPO) concentration in stool, used as a quantitative index of enteric inflammation, was measured. The incidence rate per 100 child-months of infections with Campylobacter jejuni/coli and Campylobacter species during 1-24 month follow up were 17.7 and 29.6 respectively. Female sex of child, shorter duration of exclusive breastfeeding, lower maternal age, mother having less than 3 living children, maternal educational level of <6 years, lack of routine treatment of drinking water, and unimproved sanitation were associated with Campylobacter jejuni/coli infection. The cumulative burden of both Campylobacter jejuni/coli infections and Campylobacter species were associated with poor growth and increased intestinal inflammation.

Identifiants

pubmed: 31748573
doi: 10.1038/s41598-019-53533-3
pii: 10.1038/s41598-019-53533-3
pmc: PMC6868199
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17124

Références

BMC Vet Res. 2018 Apr 4;14(1):125
pubmed: 29618371
J Pathol. 2003 Sep;201(1):17-27
pubmed: 12950013
EBioMedicine. 2017 Apr;18:109-117
pubmed: 28396264
Vaccine. 2016 Jun 8;34(27):3068-3075
pubmed: 27154394
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S220-4
pubmed: 25305290
Lancet Glob Health. 2018 Dec;6(12):e1309-e1318
pubmed: 30287127
Popul Health Metr. 2014 Mar 21;12(1):8
pubmed: 24656134
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S193-206
pubmed: 25305287
Pediatrics. 2016 Dec;138(6):
pubmed: 27940670
Lancet. 2009 Sep 19;374(9694):1032-1035
pubmed: 19766883
J Clin Microbiol. 2014 Apr;52(4):1074-80
pubmed: 24452175
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S225-32
pubmed: 25305291
World J Gastroenterol. 2010 Sep 7;16(33):4145-51
pubmed: 20806430
Nat Rev Microbiol. 2007 Sep;5(9):665-79
pubmed: 17703225
PLoS Negl Trop Dis. 2013;7(1):e2036
pubmed: 23383356
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2291-7
pubmed: 18768495
J Epidemiol Community Health. 1999 Apr;53(4):235-8
pubmed: 10396550
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S239-47
pubmed: 25305293
PLoS One. 2018 Mar 29;13(3):e0195072
pubmed: 29596493
Am J Trop Med Hyg. 2013 Feb;88(2):390-396
pubmed: 23185075
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
Clin Infect Dis. 2016 Nov 1;63(9):1171-1179
pubmed: 27501842
Am J Clin Nutr. 2017 May;105(5):1132-1138
pubmed: 28381477
Int J Epidemiol. 2003 Aug;32(4):518-26
pubmed: 12913022
PLoS Negl Trop Dis. 2018 Feb 7;12(2):e0006200
pubmed: 29415075
Clin Microbiol Rev. 2015 Jul;28(3):687-720
pubmed: 26062576
Lancet Infect Dis. 2014 Aug;14(8):716-724
pubmed: 25022434
Lancet Glob Health. 2018 Dec;6(12):e1319-e1328
pubmed: 30287125
Kurume Med J. 1998;45(1):69-73
pubmed: 9658754
Trop Med Int Health. 2018 Nov;23(11):1242-1250
pubmed: 30133067
Am J Trop Med Hyg. 2014 Jan;90(1):133-8
pubmed: 24189366

Auteurs

Md Ahshanul Haque (MA)

Nutrition and Clinical Services Division, icddr,b, Dhaka, Bangladesh. ahshanul.haque@icddrb.org.

James A Platts-Mills (JA)

Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, USA.

Estomih Mduma (E)

Haydom Lutheran Hospital, Haydom, Tanzania.

Ladaporn Bodhidatta (L)

Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.

Pascal Bessong (P)

University of Venda, Thohoyandou, South Africa.

Sadia Shakoor (S)

Aga Khan University, Karachi, Pakistan.

Gagandeep Kang (G)

Christian Medical College, Vellore, India.

Margaret N Kosek (MN)

Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, USA.
Asociación Benéfica PRISMA, Iquitos, Peru.
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Aldo A M Lima (AAM)

Clinical Research Unit and Institute of Biomedicine, Federal University of Ceara, Fortaleza, Brazil.

Sanjaya K Shrestha (SK)

Walter Reed/AFRIMS Research Unit Nepal (WARUN), Kathmandu, Nepal.

Md Ashraful Alam (MA)

Nutrition and Clinical Services Division, icddr,b, Dhaka, Bangladesh.

Alexandre Havt (A)

Clinical Research Unit and Institute of Biomedicine, Federal University of Ceara, Fortaleza, Brazil.

Amidou Samie (A)

University of Venda, Thohoyandou, South Africa.

Richard L Guerrant (RL)

Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, USA.

Dennis Lang (D)

Foundation for the National Institutes of Health, Bethesda, MD, USA.

Mustafa Mahfuz (M)

Nutrition and Clinical Services Division, icddr,b, Dhaka, Bangladesh.

Zulfiqar A Bhutta (ZA)

Aga Khan University, Karachi, Pakistan.

Eric R Houpt (ER)

Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, USA.

Tahmeed Ahmed (T)

Nutrition and Clinical Services Division, icddr,b, Dhaka, Bangladesh.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH